Sarepta Says Another Patient Died After Receiving Gene Therapy - Bloomberg.com

Sarepta Therapeutics Inc. has refused to pause all shipments of its Elevidys treatment after three deaths were linked to the company’s gene therapies, the Food and Drug Administration said Friday.